PHIBRO ANIMAL HEALTH CORP
PHIBRO ANIMAL HEALTH CORP
TEANECK, NJ
Loading...
Price History
Market Data
| Market Cap | 2.30B |
| P/E Ratio | 25.12 |
| P/B Ratio | 6.92 |
| EPS | 2.26 |
| Dividend Yield | 0.85% |
| D/E Ratio | 3.23 |
| Current Ratio | 3.05 |
| Currency | USD |
Key Financial Metrics
1.46B
Revenue
92.09M
Net Income
2.26
EPS (Diluted)
41.08M
Free Cash Flow
Profitability
Gross Margin
31.9%
Operating Margin
11.5%
Net Profit Margin
6.3%
EBITDA
252.97M
Returns & Efficiency
Return on Assets (ROA)
6.6%
Return on Equity (ROE)
27.7%
Dividend Yield
0.85%
EPS
2.26
Financial Health
Total Assets
1.41B
Total Debt
624.24M
Debt to Equity
3.23x
Current Ratio
3.05
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Food & Kindred Products |
| HQ | TEANECK, NJ |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
931.26B
P/E: --
ELI LILLY & CO
LLY
931.26B
P/E: --
543.83B
P/E: --
ABBVIE INC.
ABBV
365.53B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
281.00B
P/E: --
MERCK & CO. INC.
MRK
281.00B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$2.30B
P/E Ratio (TTM)25.1
Price to Book6.92
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin31.9%
Operating Margin11.5%
Net Margin6.3%
ROE27.7%
ROA6.6%
Leverage & Liquidity
Debt to Equity3.23
Current Ratio3.05
Total Debt$624.24M
Total Assets$1.41B
Stockholders' Equity$332.36M
Income Statement (FY 2025)
Revenue$1.46B
Gross Profit$467.02M
Operating Income$168.82M
Net Income$92.09M
EPS (Diluted)$2.26
Cash Flow (FY 2025)
Free Cash Flow$41.08M
Cash & Equivalents$55.49M
Revenue Growth13.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK, NJ 07666 |
| Phone | N/A |
| Incorporated | DE, US |
| EIN | 131840497 |
| Fiscal Year End | 0630 |
| Shares Outstanding | 40.53M |
| Stockholders' Equity | $332.36M |
| Cash & Equivalents | $55.49M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-30
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-27
Local
SCHEDULE 13D/A
Amended Schedule 13D
Amendment to Schedule 13D
Filed: 2026-04-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-16
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-14
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-07
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-31
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-19
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | PHIBRO ANIMAL HEALTH CORP |
| Ticker | PAHC |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Food & Kindred Products |
| Headquarters | TEANECK, NJ |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 2.30B |
| Revenue | 1.46B |
| Net Income | 92.09M |
| P/E Ratio | 25.12 |
| EPS | 2.26 |
| Net Margin | 6.3% |
| ROE | 27.7% |
| Dividend Yield | 0.85% |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...